The vaccinia virus-encoded Bcl-2 homologues do not act as direct bax inhibitors

Journal of Virology

Volumn 86, Issue 1, 2012, Pages 203-213

  Postigo, Antonio ^a   Way, Michael ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; PROTEIN BAX; PROTEIN BCL 2; PROTEIN INHIBITOR;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; INNATE IMMUNITY; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; VACCINIA VIRUS; VIRUS INHIBITION;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CELL LINE; HUMANS; PROTEIN BINDING; VACCINIA; VACCINIA VIRUS; VIRAL PROTEINS;

ORTHOPOXVIRUS; POXVIRIDAE; VACCINIA VIRUS;

EID: 84855928932     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05817-11     Document Type: Article

References (62)

1. Adams JM, Cory S. 2007. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr. Opin. Immunol. 19:488-496.
2. Afonso CL, et al. 2000. The genome of fowlpox virus. J. Virol. 74: 3815-3831.
3. Aoyagi M, et al. 2007. Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein. Protein Sci. 16:118-124.
4. Arakawa Y, Cordeiro JV, Way M. 2007. F11L-mediated inhibition of RhoA-mDia signaling stimulates microtubule dynamics during vaccinia virus infection. Cell Host Microbe 1:213-226.
5. Arnoult D, et al. 2004. Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proc. Natl. Acad. Sci. U. S. A. 101:7988-7993.
6. Bahar MW, et al. 2011. How vaccinia virus has evolved to subvert the host immune response. J. Struct. Biol. 175:127-134.
7. Banadyga L, Gerig J, Stewart T, Barry M. 2007. Fowlpox virus encodes a Bcl-2 homologue that protects cells from apoptotic death through interaction with the proapoptotic protein Bak. J. Virol. 81:11032-11045.
8. Banadyga L, et al. 2011. Deerpox virus encodes an inhibitor of apoptosis that regulates Bak and Bax. J. Virol. 85:1922-1934.
9. Banadyga L, Veugelers K, Campbell S, Barry M. 2009. The fowlpox virus BCL-2 homologue, FPV039, interacts with activated Bax and a discrete subset of BH3-only proteins to inhibit apoptosis. J. Virol. 83:7085-7098.
10. Bartlett N, Symons JA, Tscharke DC, Smith GL. 2002. The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J. Gen. Virol. 83:1965-1976.
11. Benfield CT, et al. 2011. Mapping the I_B kinase beta (IKK_)-binding interface of B14, a vaccinia virus inhibitor of IKK_-mediated activation of nuclear factor kappa B. J. Biol. Chem. 286:20727-20735.
12. Bowie AG, Unterholzner L. 2008. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 8:911-922.
13. Cam M, Handke W, Picard-Maureau M, Brune W. 2010. Cytomegaloviruses inhibit Bak- and Bax-mediated apoptosis with two separate viral proteins. Cell Death Differ. 17:655-665.
14. Cartron PF, et al. 2003. Nonredundant role of Bax and Bak in Bidmediated apoptosis. Mol. Cell. Biol. 23:4701-4712.
15. Cheltsov AV, et al. 2010. Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention. J. Med. Chem. 53:3899-3906.
16. Chen RA, Ryzhakov G, Cooray S, Randow F, Smith GL. 2008. Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog. 4:e22.
17. Cooray S, et al. 2007. Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J. Gen. Virol. 88:1656-1666.
18. Cordeiro JV, et al. 2009. F11-mediated inhibition of RhoA signalling enhances the spread of vaccinia virus in vitro and in vivo in an intranasal mouse model of infection. PLoS One 4:e8506.
19. Cuconati A, White E. 2002. Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev. 16:2465-2478.
20. DiPerna G, et al. 2004. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by Toll-like receptors. J. Biol. Chem. 279:36570-36578.
21. Douglas AE, Corbett KD, Berger JM, McFadden G, Handel TM. 2007. Structure of M11L: a myxoma virus structural homolog of the apoptosis inhibitor, Bcl-2. Protein Sci. 16:695-703.
22. Eitz Ferrer P, et al. 2011. Induction of Noxa-mediated apoptosis by modified vaccinia virus Ankara depends on viral recognition by cytosolic helicases, leading to IRF-3/IFN-beta-dependent induction of proapoptotic Noxa. PLoS Pathog. 7:e1002083.
23. Everett H, et al. 2000. M11L: a novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J. Exp. Med. 191:1487-1498.
24. Fischer SF, et al. 2006. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis. Cell Death Differ. 13: 109-118.
25. Gallenne T, et al. 2009. Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members. J. Cell Biol. 185:279-290.
26. Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G. 2008. Viral control of mitochondrial apoptosis. PLoS Pathog. 4:e1000018.
27. Gonzalez JM, Esteban M. 2010. A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history. Virol. J. 7:59.
28. Graham SC, et al. 2008. Vaccinia virus proteins A52 and B14 share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog. 4:e1000128.
29. Gratz MS, et al. 2011. N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection. J. Virol. 85: 3557-3569.
30. Hardwick JM, Bellows DS. 2003. Viral versus cellular BCL-2 proteins. Cell Death Differ. 10(Suppl. 1):S68-S76.
31. Hirt P, Hiller G, Wittek R. 1986. Localization and fine structure of a vaccinia virus gene encoding an envelope antigen. J. Virol. 58:757-764.
32. Hsu YT, Youle RJ. 1997. Nonionic detergents induce dimerization among members of the Bcl-2 family. J. Biol. Chem. 272:13829-13834.
33. Kalverda AP, et al. 2009. Poxvirus K7 protein adopts a Bcl-2 fold: biochemical mapping of its interactions with human DEAD box RNA helicase DDX3. J. Mol. Biol. 385:843-853.
34. Kepp O, Rajalingam K, Kimmig S, Rudel T. 2007. Bak and Bax are non-redundant during infection- and DNA damage-induced apoptosis. EMBO J. 26:825-834.
35. Kvansakul M, et al. 2007. A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak. Mol. Cell 25: 933-942.
36. Kvansakul M, et al. 2008. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ. 15:1564-1571.
37. Lindsten T, et al. 2000. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol. Cell 6:1389-1399.
38. Merino D, et al. 2009. The role of BH3-only protein Bim extends beyond inhibiting Bcl-2-like prosurvival proteins. J. Cell Biol. 186:355-362.
39. Neise D, et al. 2008. Activation of the mitochondrial death pathway is commonly mediated by a preferential engagement of Bak. Oncogene 27: 1387-1396.
40. Oltvai ZN, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
41. Pauleau AL, et al. 2007. Structure-function analysis of the interaction between Bax and the cytomegalovirus-encoded protein vMIA. Oncogene 26:7067-7080.
42. Poncet D, et al. 2004. An anti-apoptotic viral protein that recruits Bax to mitochondria. J. Biol. Chem. 279:22605-22614.
43. Postigo A, Cross JR, Downward J, Way M. 2006. Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis. Cell Death Differ. 13:1651-1662.
44. Postigo A, Ferrer PE. 2009. Viral inhibitors reveal overlapping themes in regulation of cell death and innate immunity. Microbes Infect. 11: 1071-1078.
45. Postigo A, Martin MC, Dodding MP, Way M. 2009. Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-apoptotic protein F1L synergize to suppress cell death during infection. Cell. Microbiol. 11:1208-1218.
46. Puthalakath H, Strasser A. 2002. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9:505-512.
47. Rottger S, Frischknecht F, Reckmann I, Smith GL, Way M. 1999. Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J. Virol. 73:2863-2875.
48. Roulston A, Marcellus RC, Branton PE. 1999. Viruses and apoptosis. Annu. Rev. Microbiol. 53:577-628.
49. Schroder M, Baran M, Bowie AG. 2008. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J. 27:2147-2157.
50. Stewart TL, Wasilenko ST, Barry M. 2005. Vaccinia virus F1L protein is a tail-anchored protein that functions at the mitochondria to inhibit apoptosis. J. Virol. 79:1084-1098.
51. Su J, et al. 2006. Myxoma virus M11L blocks apoptosis through inhibition of conformational activation of Bax at the mitochondria. J. Virol. 80: 1140-1151.
52. Taylor JM, Barry M. 2006. Near death experiences: poxvirus regulation of apoptotic death. Virology 344:139-150.
53. Taylor JM, Quilty D, Banadyga L, Barry M. 2006. The vaccinia virus protein F1L interacts with Bim and inhibits activation of the proapoptotic protein Bax. J. Biol. Chem. 281:39728-39739.
54. Tulman ER, et al. 2004. The genome of canarypox virus. J. Virol. 78: 353-366.
55. Wang G, et al. 2004. Myxoma virus M11L prevents apoptosis through constitutive interaction with Bak. J. Virol. 78:7097-7111.
56. Wasilenko ST, Banadyga L, Bond D, Barry M. 2005. The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J. Virol. 79:14031-14043.
57. Wasilenko ST, Stewart TL, Meyers AF, Barry M. 2003. Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis. Proc. Natl. Acad. Sci. U. S. A. 100:14345-14350.
58. Wei MC, et al. 2001. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730.
59. Westphal D, et al. 2007. A novel Bcl-2-like inhibitor of apoptosis is encoded by the parapoxvirus ORF virus. J. Virol. 81:7178-7188.
60. Westphal D, et al. 2009. The orf virus inhibitor of apoptosis functions in a Bcl-2-like manner, binding and neutralizing a set of BH3-only proteins and active Bax. Apoptosis 14:1317-1330.
61. Youle RJ, Strasser A. 2008. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell. Biol. 9:47-59.
62. Zhai D, et al. 2010. Vaccinia virus protein F1L is a caspase-9 inhibitor. J. Biol. Chem. 285:5569-5580